TAGCYX BIOTECHNOLOGIES
TagCyx’s scientific team has established its proprietary Xenoligo® technology platform, allowing high functional oligonucletide drug discovery. The Xenoligo® platform utilizes genetic alphabet expansion by unnatural base-pairs to generate customized nucleic acid suited for therapeutic applications.
TAGCYX BIOTECHNOLOGIES
Industry:
Biotechnology Environmental Consulting
Founded:
2007-03-01
Address:
Tokyo, Tokyo, Japan
Country:
Japan
Website Url:
http://www.tagcyx.com
Total Employee:
1+
Status:
Active
Contact:
+81-3-6407-1672
Email Addresses:
[email protected]
Total Funding:
1.41 B JPY
Technology used in webpage:
Euro CrUX Dataset Pound Sterling CrUX Top 10m Japanese Yen Akismet Akismet Non Hosted
Similar Organizations
OncoHost
OncoHost is a clinical-stage biotechnology company developing personalized strategies to increase the success of cancer therapy.
Transcenta
Transcenta is a global biotherapeutic company that fully integrates antibody-based biotherapeutics discovery, R&D and manufacture.
Current Advisors List
Current Employees Featured
Investors List
UTokyo Innovation Platform
UTokyo Innovation Platform investment in Venture Round - TAGCyx Biotechnologies
Healthcare Innovation
Healthcare Innovation investment in Venture Round - TAGCyx Biotechnologies
SBI Group
SBI Group investment in Venture Round - TAGCyx Biotechnologies
UTokyo Innovation Platform
UTokyo Innovation Platform investment in Venture Round - TAGCyx Biotechnologies
UTokyo Innovation Platform
UTokyo Innovation Platform investment in Series B - TAGCyx Biotechnologies
Mizuho Capital
Mizuho Capital investment in Series B - TAGCyx Biotechnologies
SMBC Venture Capital
SMBC Venture Capital investment in Series B - TAGCyx Biotechnologies
UTEC - The University of Tokyo Edge Capital Partners
UTEC - The University of Tokyo Edge Capital Partners investment in Series B - TAGCyx Biotechnologies
Nissay Capital
Nissay Capital investment in Venture Round - TAGCyx Biotechnologies
UTEC - The University of Tokyo Edge Capital Partners
UTEC - The University of Tokyo Edge Capital Partners investment in Venture Round - TAGCyx Biotechnologies
Official Site Inspections
http://www.tagcyx.com Semrush global rank: 11.56 M Semrush visits lastest month: 156
- Host name: www1066.sakura.ne.jp
- IP address: 219.94.129.76
- Location: Osaka Japan
- Latitude: 34.6848
- Longitude: 135.5142
- Timezone: Asia/Tokyo
- Postal: 543-0062
More informations about "TAGCyx Biotechnologies"
Company Information | TAGCyx Biotechnologies, Inc.｜Aptamer …
TAGCyx is a research based company based in Tokyo (Japan), founded in March 2007 as a spin out company of RIKEN. TAGCyx’s scientific team has established its proprietary Xenoligo® …See details»
TAGCyx Biotechnologies - Crunchbase Company Profile & Funding
TagCyx’s scientific team has established its proprietary Xenoligo® technology platform, allowing high functional oligonucletide drug discovery. The Xenoligo® platform utilizes genetic alphabet …See details»
TAGCyx Biotechnologies, Inc.｜Aptamer Apheresis …
TAGCyx Bio can create DNA aptamers through drug discovery platform technology “Xenoligo®” based on innovative artificial base pairing technology. Aptamers are the next generation drug modality consisting of single-stranded …See details»
Company Overview | TAGCyx Biotechnologies, Inc.｜Aptamer …
Company Name TAGCyx Biotechnologies, Inc. Establishment 22nd March, 2007 President Chizuko Koseki, Ph.D Address Tokyo University, Komaba Open Laboratory 403, 4-6-1 …See details»
タグシクス・バイオ株式会社｜アプタマー 核酸医薬 アフェレシ …
タグシクス・バイオは革新的な新規人工塩基対技術を用いた創薬プラットフォーム技術によってdnaアプタマーを創出します。抗体に続く次世代の新薬モダリティであり、私達は効果が高 …See details»
TAGCYX BIOTECHNOLOGIES INC. - LinkedIn
TAGCYX BIOTECHNOLOGIES INC. Biotechnology Tokyo, Tokyo 207 followers Established its proprietary Xenoligo® technology platform, allowing high functional oligonucletide drug discovery.See details»
CAGE Bio, TAGCyx and PeptiStar announce execution of a license …
Manufacturing Organization (CDMO) for peptide and oligonucleotide drugs will manufacture TAGX-0003 for clinical trials and possible future commercialization. Dr. Nitin Joshi, CEO of …See details»
TAGCYX BIOTECHNOLOGIES,INC. - Dun & Bradstreet
Tagcyx biotechnologies,inc. d&b business directory home / business directory / manufacturing / chemical manufacturing / pharmaceutical and medicine manufacturing / japan / tokyo / meguro …See details»
TAGCyx Biotechnologies - Crustdata Company Profile, Funding …
TagCyx is a research based company based in Tokyo (Japan), founded in March 2007 as a spin out company of RIKEN. Suggest an Edit. Biotechnology. Environmental Consulting. Unlock …See details»
TagCyx Biotechnologies - Craft
TagCyx Biotechnologies is a company developing DNA aptamers for therapeutic purposes. It uses Xenoligo, its proprietary nucleic acid technology platform that utilizes genetic alphabet …See details»
TAGCyx - VentureRadar
TagCyx is a research based company based in Tokyo (Japan), founded in March 2007 as a spin out company of RIKEN. TagCyx’s scientific team has established its proprietary Xenoligo® …See details»
Global Startup Acceleration Program (GSAP) Alumnis TAGCyx ...
TAGCyx Biotechnologies is a privately owned preclinical stage start-up biotech developing oligonucleotide aptamer-based pharmaceuticals and medical devices. Our mission is to …See details»
TAGCyx Biotechnologies - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors ... Apr 27, 2020: Venture Round - TAGCyx Biotechnologies . 1: …See details»
TAGCyx Biotechnologies - Overview, News & Similar companies
TAGCyx developed "Xenoligo®" aptamers with high affinity and specificity for proteins, and utilizes this technology to generate drugs and conduct joint development with pharmaceutical …See details»
Tagcyx Biotechnologies KK (Tagcyx Biotechnologies KK) - 药物管 …
Mar 7, 2025 2024.03.11 News Release March 8th, 2024 TAGCyx biotechnologies Inc. TAGCyx biotechnologies Inc. (President and CEO: Chizuko Koseki), and Shinji Oki, PhD, at National …See details»
CAGE Bio, TAGCyx, and PeptiStar Announce Execution of a
Sep 15, 2022 CAGE Bio Inc. and TAGCyx Biotechnologies Inc. announce the execution of a license agreement for development of TAGX-0003 for the targeted treatment of alopecia areata and vitiligo by dermatological application. ... PeptiStar Inc. (hereinafter “PeptiStar”), a technology-based contract development and manufacturing organization (CDMO) for ...See details»
CAGE Bio and TAGCyx announced execution of a license …
Sep 8, 2022 TAGCyx Bio can create DNA aptamers through drug discovery platform technology “Xenoligo®” based on innovative artificial base pairing technology. ... (Contract Development …See details»
Company History | TAGCyx Biotechnologies, Inc.｜Aptamer …
Established TAGCyx Biotechnologies Inc. 2009 Development of Ds-Px base pair technology Detail 2015 Aptamer stabilization technology 2016 Next generation aptamer stabilization …See details»
タグシクス・バイオ株式会社｜スピーダ スタートアップ情報リ …
独自の人工塩基対技術による創薬プラットフォームをベースとした医薬品開発を展開。 DNAポリメラーゼによるDNA増幅、並びにRNAポリメラーゼによるRNAへの転写を可能にする人工 …See details»
TagCyx-TagCyx Biotechnologies-企业详情-InvestGO数据库 …
查看医药魔方InvestGO®数据库TagCyx的公司信息。TagCyx（TagCyx Biotechnologies），公司简介：agCyx is a research based company based in Tokyo (Japan), founded in March 2007 …See details»